SAN ANTONIO — The San Antonio Spurs announced season-altering news Thursday when the team revealed that Victor Wembanyama, ...

San Antonio star Victor Wembanyama’s season is likely over after he was diagnosed with a blood clot in his right shoulder.

The Spurs are signaling optimism, with a team source telling The Athletic that Wembanyama is expected to be fully healthy and ...

Victor Wembanyama, the reigning NBA rookie of the year, is out for the rest of the season with deep vein thrombosis in his ...

San Antonio Spurs superstar Victor Wembanyama will likely miss the rest of the season because of deep vein thrombosis. What ...

San Antonio Spurs player Victor Wembanyama is out for 2025 due to deep vein thrombosis, a similar condition to what ended ...

Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab ...

South Korea-based Celltrion today announced that the European Commission (EC) has granted marketing authorization for three ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

The following is a summary of “Associations between a healthy lifestyle score and retinal neurovascular health,” published in ...